Brief: GlaxoSmithKline’s 2017 Q1 Result

GlaxoSmithKline today released Unaudited  Interim Financial Statements for the three months ended 31 March 2017.

Revenue N’million

Q1 2017| N3,850

Q1 2016| N4,152

%age change|-7%

(Loss)/Profit after tax  N’million

Q1 2017| N-8

Q1 2016| N116

%age change| N/A

EPS (Kobo)

Q1 2017|-1k

Q1 2016|10k

%age change|N/A%

[gview file=”https://nairametrics.com/wp-content/uploads/2017/04/GLAXOSMITHKLINE-Q1_MARCH_2017_FINANCIAL_STATEMENTS_APRIL_2017.pdf”]